From out of the rubble, something new emerges: Despite the decades-long decline of assembly-line, smokestack-style manufacturing in Philadelphia, there is new growth in small-scale makers and artisans. A key ingredient in that shift is the city’s incubators and makerspaces.
Few women around the world can get a mammogram. They are far from a clinic, or lack the money, or just don’t know about breast cancer. But now there’s another kind of breast exam that could reach women that mammograms don’t.
Meet Lia: At-Home Pregnancy Steps Into The 21st Century
As a professor who teaches entrepreneurship, I’m often asked if it can truly be taught. Unsurprisingly, my answer is yes. To back up that assertion, I’d like to share the story of a terrific company that came about because of a school assignment: Lia Diagnostics, co-founded by Bethany Edwards and Anna Simpson.
AUM LifeTech, CHOP and Penn Partnering to Advance Cancer Immunotherapy Against Lung Cancer Using Foxp3 Gene Silencing FANA ASO Therapy
AUM LifeTech, Inc., a Philadelphia-based biotech company, has partnered with the Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania to employ next-generation RNA silencing FANA technology as a new approach to cancer immunotherapy designed to treat lung cancer. The preclinical results were presented at the 2018 Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) in Seattle, WA.
Integral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies
Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that they have entered into a collaboration on multiple undisclosed targets.